Expert consensus on early diagnosis and treatment of bladder cancer (2024 edition)

Abstract

Bladder cancer is one of the common cancers of urinary system, which seriously threatens the life and health of Chinese population. In recent years, with the extension of life expectancy and the acceleration of aging, the incidence and mortality rates of bladder cancer are increasing year by year. Enhancing the detection rate of early bladder cancer followed by prompt and effective treatment can not only improve the prognosis and quality of life of patients, but also reduce their economic burden. However, there is still a lack of standardization for early diagnosis and treatment of bladder cancer in China. Therefore, based on the recent guidelines, research and clinical practice experience of bladder cancer, clinical experts in Urologic Chinese Oncology Group summarized and refined the opinions from expert meeting and Delphi questionnaire survey, and finally developed “expert consensus on early diagnosis and treatment of bladder cancer (2024 edition)”. We hope that this consensus will promote the standardization for early diagnosis and treatment of bladder cancer in China, and provide corresponding guidance and standardized criteria for urologic oncologist. The consensus has been registered on Practice guideline REgistration for transPAREncy (PREPARE) with the registration number PREPARE-2024CN458.

Keywords

• |bladder cancer|early diagnosis and treatment|consensus